MEMBERS WEALTH LLC: IVE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MEMBERS WEALTH LLC on IVE, newest first. How the timeline and the estimate are built.
MEMBERS WEALTH LLC held 3,004 IVE shares at 2026-06-30 per its 13F-HR filed 2026-07-09.
the latest 13F is the newest step
- period ended2026-06-3013F 3,004 sharesChange vs previous 13F -250 shares
0.37% of the 13F portfolio, value $682,152.
13F-HR 0001951757-26-000963 filed by MEMBERS WEALTH LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 3,254 sharesChange vs previous 13F +30 shares
0.43% of the 13F portfolio, value $716,293.
13F-HR 0001951757-26-000720 filed by MEMBERS WEALTH LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 3,224 sharesChange vs previous 13F -1,076 shares
0.44% of the 13F portfolio, value $700,113.
13F-HR 0001951757-26-000321 filed by MEMBERS WEALTH LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,300 sharesChange vs previous 13F -617 shares
0.56% of the 13F portfolio, value $890,297.
13F-HR 0001951757-25-001419 filed by MEMBERS WEALTH LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,917 sharesChange vs previous 13F -750 shares
0.71% of the 13F portfolio, value $937,081.
13F-HR 0001951757-25-000371 filed by MEMBERS WEALTH LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 5,667 sharesChange vs previous 13F not available
0.83% of the 13F portfolio, value $1,108,351.
13F-HR 0001951757-25-000280 filed by MEMBERS WEALTH LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).